WHO pointers call for manufacturers to put into action a continual chance administration course of action for sterility test isolators, which includes regular possibility assessments and the development of possibility-based mostly Manage procedures. The WHO's suggestions provide not only being a regulatory framework but also like a roadmap for waiting for link from Forum Profiles (11)